Filters close
Release date: 5-Dec-2024 4:45 PM EST
Anthem Anesthesia Reimbursement Changes Highlight Need for HHS to Enforce ACA Provider Non-Discrimination Provision
American Association of Nurse Anesthesiology

The American Association of Nurse Anesthesiology (AANA) is pleased Anthem Blue Cross Blue Shield reversed its recently announced anesthesia reimbursement policy that could have endangered patients.

UNREVIEWED

Newswise: Controlling cancer cells’ gluttony for glutamine
Release date: 5-Dec-2024 4:40 PM EST
Controlling cancer cells’ gluttony for glutamine
Sanford Burnham Prebys

Researchers at the NCI-Designated Cancer Center at Sanford Burnham Prebys describe two enzymes newly identified for their roles in regulating macropinocytosis, a process cancer cells use to snatch extra nutrients from the jelly-like substance between cells. This allows tumors to fuel their growth even when they consume more energy and other resources than they can acquire from nearby blood vessels.

UNREVIEWED

Newswise: image.jpg
Release date: 5-Dec-2024 4:05 PM EST
Cybercrime expert explains how to guard against new scammer tactics
Virginia Tech

The potential for record-breaking online sales this holiday season unfortunately signifies opportunities for holiday scams, and as technology advances, so do the tactics of scammers. Virginia Tech cybercrime expert Katalin Parti shared tips for new scammer tactics to guard against, through the holiday season and beyond.

UNREVIEWED

Newswise: Analyzing Multiple Mammograms Improves Breast Cancer Risk Prediction
4-Dec-2024 12:25 PM EST
Analyzing Multiple Mammograms Improves Breast Cancer Risk Prediction
Washington University in St. Louis

A new method of analyzing mammograms — developed by researchers at WashU Medicine — identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did. The new method, powered by artificial intelligence, could help diagnose cancer earlier and guide recommendations for earlier screening, additional imaging or risk-reducing medications.

Release date: 5-Dec-2024 3:35 PM EST
3DBIOLABS ACHIEVES PIVOTAL MILESTONE IN DEVELOPMENT OF 3D PRINTED LIVER IMPLANT
3D BioLabs

3D BioLabs LLC ("3D BioLabs" or "3DB"), has reached a pivotal milestone in the field of regenerative medicine as recently published in the Proceedings of the National Academy of Sciences. 3DB's study has demonstrated a new approach to creating large organs to solve the organ transplant shortage. Using 3D printing, computational fluid dynamics, and organ-specific cells, their study demonstrated effective blood flow and cell viability and function within the model device, marking a significant advance toward a bioengineered liver replacement. The study was led by 3D BioLabs Scientific Founder Dr. Joseph P. Vacanti, the Distinguished John Homans Professor of Surgery at Harvard Medical School and Mass General Hospital.

UNREVIEWED

Newswise: 5 Trends That Are Changing Pediatric Epilepsy Care
Release date: 5-Dec-2024 3:15 PM EST
5 Trends That Are Changing Pediatric Epilepsy Care
Children's Hospital Los Angeles

Epilepsy is the most common pediatric brain disorder, affecting nearly half a million children in the U.S. And yet, only about 1% of patients who should be seen at a comprehensive epilepsy center are ever referred to this care.That’s a devastating statistic, especially for children—whose uncontrolled seizures can sometimes lead to irreversible developmental deficits.

UNREVIEWED

Newswise: Seven researchers named to Battelle Distinguished Inventor cadre
Release date: 5-Dec-2024 3:10 PM EST
Seven researchers named to Battelle Distinguished Inventor cadre
Oak Ridge National Laboratory

Seven scientists affiliated with the Department of Energy’s Oak Ridge National Laboratory have been named Battelle Distinguished Inventors in recognition of being granted 14 or more United States patents. Since Battelle began managing ORNL in 2000, 104 ORNL researchers have reached this milestone.

UNREVIEWED

Newswise: Earthquake seismology expert, Dr. Stephen Gao, available for comment on California earthquake
Release date: 5-Dec-2024 3:10 PM EST
Earthquake seismology expert, Dr. Stephen Gao, available for comment on California earthquake
Missouri University of Science and Technology

Dr. Stephen Gao is available for comment related to the science behind the recent earthquake in California.

UNREVIEWED

Newswise: Ellis_portrait.jpg
Release date: 5-Dec-2024 3:00 PM EST
Media Advisory: Virginia Tech expert explains NOAA forecast for mild winter in mid-Atlantic region
Virginia Tech

Drew Ellis, a professor in the Department of Geography and an expert in climate science, explains the National Oceanic and Atmospheric Administration's winter outlook, which predicts a mild winter for the mid-Atlantic region of the United States.

UNREVIEWED

Release date: 5-Dec-2024 2:50 PM EST
Beyond the ban: FSU expert available to comment on the effects of social media on youth mental health
Florida State University

Over the Thanksgiving holiday, Australia created worldwide attention when the country approved a social media ban for children 16 years old and under, marking one of the most aggressive policies at curbing youth addiction to apps like Facebook, Instagram, X and TikTok.Vanessa Dennen, a professor of Instructional Systems & Learning Technologies at the Florida State University Department of Educational Psychology & Learning Systems, has been actively researching the cognitive, motivational and social elements of computer-mediated communication.

UNREVIEWED

Release date: 5-Dec-2024 2:35 PM EST
New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
Washington University in St. Louis

Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a life-threatening side effect called graft-versus-host disease. Results from a clinical trial conducted by researchers at WashU Medicine showed adding the investigational drug itacitinib to standard care for "half-matched" stem cell transplantation may reduce rates of the disease, in which the donor’s stem cells attack the patient’s healthy tissues.

UNREVIEWED

Newswise: Rutgers Public Health Research Illustrates Rise in Use of Paid Family Leave in New Jersey
Release date: 5-Dec-2024 2:30 PM EST
Rutgers Public Health Research Illustrates Rise in Use of Paid Family Leave in New Jersey
Rutgers University-New Brunswick

Rutgers School of Public Health research found that New Jersey’s expansion of the Family Leave Insurance program in 2019 and 2020 was associated with a sharp increase in the use of family leave benefits among state residents.

UNREVIEWED

Release date: 5-Dec-2024 2:10 PM EST
Drug Offers Cost-Effective Protection for Newborns with Genetic Bleeding Disorder
Yale Cancer Center/Smilow Cancer Hospital

Severe hemophilia A is a genetic disorder that prevents blood from clotting properly, posing a constant risk of dangerous bleeding episodes. Infants with severe hemophilia A (HA) are at risk of brain bleeds, which can lead to serious long-term brain damage. Emicizumab (Hemlibra) was approved by the FDA in 2018 to prevent and reduce bleeding for patients who suffer from hemophilia A.

UNREVIEWED

Release date: 5-Dec-2024 1:50 PM EST
U of U Researchers Receive Multi-Million-Dollar Grant to Advance Epidemic Prevention and Detection Worldwide
University of Utah Health

A multinational consortium including the University of Utah has been awarded a $246 million federal contract by USAID to improve infectious disease detection and monitoring across the globe.

UNREVIEWED

Newswise: U-M Rogel Cancer Center names 2 new clinical research leaders
Release date: 5-Dec-2024 1:30 PM EST
U-M Rogel Cancer Center names 2 new clinical research leaders
Michigan Medicine - University of Michigan

The University of Michigan Rogel Cancer Center has named Kyle Cuneo, M.D., its new associate director for clinical research. In addition, a new position of assistant director for clinical research will be filled by John Magenau, M.D. Cuneo and Magenau will collaborate with leaders across Michigan Medicine and the University of Michigan to establish processes and infrastructure in support of cancer-focused clinical research.

UNREVIEWED

Newswise: That’s no straw: Hummingbirds evolved surprisingly flexible bills to help them drink nectar
Release date: 5-Dec-2024 1:30 PM EST
That’s no straw: Hummingbirds evolved surprisingly flexible bills to help them drink nectar
University of Washington

Scientists have discovered that the hummingbird bill is surprisingly flexible. While drinking, a hummingbird rapidly opens and shuts different parts of its bill simultaneously, engaging in an intricate and highly coordinated dance with its tongue to draw up nectar at lightning speeds.

UNREVIEWED

Release date: 5-Dec-2024 1:20 PM EST
Tyber Medical Achieves Class III MDR CE Mark Certification from BSI for PEEK Titanium Plasma-Coated Cervical Cages
Tyber Medical, LLC

Tyber Medical LLC, a leading provider of private-label orthopedic and spinal implants, proudly announces that it has received Medical Device Regulation (MDR) CE Mark certification from BSI for its PEEK Titanium Plasma-coated cervical cages. This certification for Tyber Medical's innovative technology is a pivotal step toward bringing the company's extensive product portfolio to the global market, aligning with stringent European Union regulatory standards for quality, safety, and performance.

UNREVIEWED

Newswise: NASA's Hubble Takes the Closest-Ever Look at a Quasar
Release date: 5-Dec-2024 1:00 PM EST
NASA's Hubble Takes the Closest-Ever Look at a Quasar
Space Telescope Science Institute (STScI)

Astronomers have used Hubble to see closer than ever into an energetic monster black hole powering 3C 273, the first quasar ever discovered. The new image details a lot of weird things: filaments, lobes, and a mysterious L-shaped structure, all within 16,000 light-years of the black hole.

UNREVIEWED



close
0.14353